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AbstrACt 
Introduction Conventional risk assessment in cardiac 
surgery focus on medical and physiological factors 
and have been developed to predict mortality. Other 
relevant risk factors associated with increased risk 
of poor outcomes are not included. Adding non-
medical variables as potential prognostic factors to 
risk assessments direct attention away from specific 
diagnoses towards a more holistic view of the 
patients and their predicament. The aim of this paper 
is to describe the method and analysis plan for the 
development and validation of a prognostic screening 
tool as a supplement to the European System for 
Cardiac Operative Risk Evaluation (EuroSCORE) to 
predict mortality, readmissions and prolonged length 
of admission in patients within 90 days after cardiac 
surgery, as individual outcomes.
Methods and analysis The development of 
a prognostic screening tool with inclusion of 
emotional, behavioural, social and functional factors 
complementing risk assessment by EuroSCORE will 
adopt the methods recommended by the PROGnosis 
RESearch Strategy Group and report using the 
Transparent Reporting of a multivariable prediction 
model for Individual Prognosis Or Diagnosis statement. 
In the development stage, we will use data derived from 
three datasets comprising 1143, 3347 and 982 patients 
for a prospective cohort study of patients undergoing 
cardiac surgery, respectively. We will construct logistic 
regression models to predict mortality, prolonged length 
of admission and 90-day readmissions. In the validation 
stage, we will use data from a separate sample of 
333 patients planned to undergo cardiac surgery to 
assess the performance of the developed prognostic 
model. We will produce validation plots showing the 
overall performance, area under the curve statistic for 
discrimination and the calibration slope and intercept.
Ethics and dissemination The study will follow the 
requirements from the Ethical Committee System 
ensuring voluntary participation in accordance with the 
Helsinki declarations. Data will be filed in accordance 
with the requirements of the Danish Data Protection 
Agency.
IntroduCtIon
Today cardiac surgery is being performed on 
an older, more complex and high-risk popu-
lation than ever. This calls for tertiary preven-
tive initiatives for preventing poor outcomes 
such as mortality and readmissions based on 
prognostic factors.1–6 Prognostic factors can 
be combined to produce prognostic models 
used to screen patients into risk groups.7 
Early identification of at-risk patients allows 
healthcare professionals to make informed 
decisions based on prognostic profiles and 
enables patients to understand the possible 
risks of surgery. Conventional prognostic 
screening tools focus on medical and phys-
iological factors, but do not contain other 
risk factors associated with poor outcomes 
following cardiac surgery.8 
There are several prognostic screening 
tools currently available for patients under-
going cardiac surgery. In most of Europe 
European System for Cardiac Operative 
Risk Evaluation (EuroSCORE)9 10 is used in 
strengths and limitations of this study
 ► Follows the PROGnosis RESearch Strategy frame-
work, and Transparent Reporting of a multivari-
able prediction model for Individual Prognosis 
Or Diagnosis reporting guidelines for prognostic 
research.
 ► Prespecifies statistical analysis plan and informative 
levels of tool performance to increase transparency 
of results and of the final reporting.
 ► Use of national administrative registers.
 ► Restricted to the use of predictor variables mea-
sured in previous datasets.
 ► Minor differences in the way variables are mea-
sured between the development and the validation 
datasets.
Protected by copyright.
 o
n
 Septem
ber 26, 2019 at Kobenhavns Universitets Bibliotek.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-026745 on 3 July 2019. Downloaded from 
2 Cromhout PF, et al. BMJ Open 2019;9:e026745. doi:10.1136/bmjopen-2018-026745
Open access 
clinical practice. EuroSCORE was developed for in-hos-
pital and 30-day mortality and has been widely used and 
recommended for clinical use, not only for operative risk 
prediction but also for the assessment of the quality of 
cardiac surgery.9–12 The total risk is calculated by adding 
scores from several risk factors (eg, chronic pulmonary 
disease, serum creatinine and left ventricular dysfunc-
tion) resulting in a predicted percentage of surgical 
mortality. The score with a range of 0–22 is defined to 
distinguish low (<3), moderate (3–5) and high-risk 
groups (6+).9 10 However, validation studies have reported 
that EuroSCORE is inaccurate in predicting mortality 
rates.13–15
Indeed, there is mounting evidence that non-physio-
logical factors, such as emotional,16–18 behavioural,19–21 
social22–27 and functional28 29 factors are predictive of poor 
outcomes following cardiac surgery.8 Adding non-med-
ical variables as potential prognostic factors directs 
attention away from specific diagnoses towards a more 
holistic view of the patient and their predicament. The 
study described in this protocol is planned as the devel-
oping and validation of risk stratification models comple-
menting EuroSCORE with emotional, behavioural, social 
and functional factors to predict mortality, readmissions 
and prolonged length of admission in patients within 90 
days after cardiac surgery.
Most existing prognostic tools have been developed to 
predict mortality only. Mortality is a reliable and clinically 
important outcome in cardiac surgery; however, there are 
other measures and other adverse outcomes that might 
be worth considering. One of these is readmission, which 
is an outcome with significant health and economic impli-
cations.4 Another important process outcome in cardiac 
surgery is prolonged length of stay in the intensive care 
unit (ICU) and in hospital.30
The aim of this paper is to describe the method and 
analysis plan for the development and validation of a 
prognostic screening tool as a supplement to EuroSCORE 
to predict mortality, readmissions and prolonged length 
of stay in patients within 90 days after cardiac surgery.
MEthods And AnAlysIs
The study is based on data from different data sources 
allocated to different datasets. Primary outcome is death 
and secondary outcomes are prolonged length of ICU 
stay and hospital admission as well as readmissions, all 
within 90 days from the time of cardiac surgery. Inclu-
sion criteria are age ≥18 years and planned for or having 
undergone cardiac surgery. Patients will be excluded if 
data on EuroSCORE are not available. Multiple regression 
analyses will be performed to investigate the association 
between emotional, social, functional and behavioural 
variables and outcomes. In the model development, Euro-
SCORE is included while each potential predictor will be 
removed stepwise from the model by using an automated 
backwards selection procedure. The final model will be 
prospectively tested to determine its predictive validity.
study design and study population
This paper is inspired by the PROGnosis RESearch 
Strategy (PROGRESS) framework6 7 31 32 and will be 
reported in accordance with the Transparent Reporting 
of a multivariable prediction model for Individual Prog-
nosis Or Diagnosis (TRIPOD).33 34 This is V.1.2 of the 
protocol.
Cardiac surgery typically includes standardised proce-
dures especially for coronary artery bypass grafting and 
aortic valve surgery.35 36 For specific classification of 
included procedures, see online supplementary table 1.
development stage
Development sample
In the development stage, prognostic factors will be iden-
tified and combined to a prognostic model based on 
emotional, behavioural, social and functional factors in 
addition to the EuroSCORE to predict mortality, read-
missions and prolonged length of admission in patients 
within 90 days after cardiac surgery. See figure 1 for a 
schematic presentation of the prognostic prediction 
modelling. The need for follow-up beyond the traditional 
30 days, has previously been advanced since the 30-day 
mortality only reflects part of early mortality after cardiac 
surgery.37
The development sample consists of three datasets 
(table 1). Dataset 1 consists of primary data collected from 
October 2016 to February 2018. Included patients partic-
ipated in a preoperative survey including all patients ≥18 
years planned for cardiac surgery at Copenhagen Univer-
sity hospital, Rigshospitalet (n=1143). Sample size were 
estimated based an expected incidence of death following 
cardiac surgery of 3.5% and including four covariates 
(see table 2). Information on preoperative symptoms of 
anxiety, depression and frailty (when aged ≥70 years) are 
included (see flowchart, figure 2). Dataset 2 consists of 
existing data from Danish national registers, including 
Figure 1 Schematic presentation of prognostic prediction 
modelling study.
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all patients having undergone cardiac surgery from April 
2013 to April 2014 at all four Danish hospitals performing 
cardiac surgery (n=3217). Information on socioeconomic 
factors and cohabitation are obtained through register 
linkage (see flow-chart, figure 3). Dataset 3 is a subsa-
mple of dataset 2 and includes all patients who partici-
pated in the DenHeart study (n=982), a national survey 
including all cardiac diagnostic groups.38 Information 
on self-reported health and quality of life were collected 
on discharge through validated questionnaires (see flow-
chart, figure 4).
The three datasets will be linked with national adminis-
trative registers for information on mortality, prolonged 
length of stay and readmissions.
Data sources
Two population-based, administrative registers were used 
in this study: (1) the Danish National Patient Register 
(DNPR), which has registered information on somatic 
conditions leading to hospitalisation since 1978 and, 
from 1995, also outpatient visits39 and (2) the Danish 
Civil Registration System (CRS). All Danish residents 
have since 1968 been assigned a unique personal iden-
tification number and have been registered in the CRS 
by date of birth, sex, marital status, migration and vital 
status.40 The personal identification number allows accu-
rate linkage with national administrative registers. These 
registers have previously been well validated.40 41 The clin-
ical databases utilised for information on EuroSCORE 
and ICU admission cover all regions of Denmark. For 
Eastern Denmark, EuroSCORE II was not implemented 
for the time period covering datasets 2 and 3. According 
to the yearly reports data completeness for risk profile is 
100% and ≥98% for ICU admission.42
The DenHeart study was a cross-sectional survey 
conducted April 2013 to April 2014, consisting of six vali-
dated questionnaires and several ancillary questions, with 
a total of 80 questions. The survey included nine ques-
tions about health and health behaviour from the Danish 
Health and Morbidity Survey and the Danish National 
Health Survey43 and one question regarding medication 
adherence. All cardiac patients were asked to fill out the 
questionnaire at hospital discharge to evaluate patient-re-
ported outcomes.38 The survey data were combined 
with data from the registers by matching with a hospital 
discharge from the DNPR.
outcomes
One primary and three secondary outcomes are included 
in this study. Each of the outcomes will be evaluated 
individually.
Primary outcome
The primary outcome is mortality up to 90 days after 
cardiac surgery.
Secondary outcomes
Readmissions
Nearly 20% of patients undergoing cardiac surgery 
require acute readmission after surgery.4 That makes 
readmissions following cardiac surgery an outcome with 
significant health and economic implications. Readmis-
sion will be included as a dichotomous outcome within 
90 days following cardiac surgery. However, as supplemen-
tary analyses the number of readmissions as well as time 
to hospital readmission within 90 days will be included.
Prolonged length of stay
Prolonged length of stay will be measured by the number 
of days in the ICU, as well as total length of hospital stay. 
Table 1 Prespecification of predictor variables with initial df 
allocation
Variable df Codes/values
Social 
factors
Educational level 2 0=Basic school
1=Upper secondary 
or vocational school
2=Higher education
Equivalised 
disposable 
income
2 0 = ≤50% median
1 = >50%–
150% median
2 = ≥150% median
Cohabitation 
status
1 0=Non-cohabitation
1=Cohabitation
Functional 
factors
Frailty—Gait 
speed test
1 0=No
1=Yes
SF-12, physical 
component scale
1 0 = ≥mean −1 SD
1 = <mean −1 SD
HeartQoL—
physical
1 0 = ≥median
1 = <median
Behavioural 
factors
Smoking 2 0=Never
1=Former
2=Current
Alcohol abuse 
male: >21 drinks/
week
Women: >14 
drinks/week
1 0=No
1=Yes
Body mass index 2 0 = ≤25
1=26–30
2 = >30
Emotional 
factors
SF-12, mental 
component scale
1 0 = ≥mean −1 SD
1 = <mean −1 SD
HADS—anxiety 2 0 = <8
1=8–10
2 = ≥11
HADS—
depression
2 0 = <8
1=8–10
2 = ≥11
HeartQoL—global 1 0 = ≥median
1 = <median
HeartQoL—
emotional
1 0 = ≥median
1 = <median
HADS, Hospital Anxiety and Depression Scale; SF-12, 12-Item 
Short-Form Health Survey.
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The length of stay outcome is used as a proxy for compli-
cations assuming minor complications will increase the 
length of the total hospital stay and major complications 
will increase the length of stay in the ICU.
Length of hospital stay, and ICU stay will be dichoto-
mised to designate normal and prolonged length of stay. 
There is no consensus on the definition of prolonged 
length of stay following cardiac surgery. Previous studies 
have adopted the 75th percentile of the length of stay 
distribution, while others have defined prolonged length 
of stay as hospitalisation of >11 days following cardiac 
surgery,3 44 which will be used in this study.
Duration of stay in the ICU is a common endpoint in 
cardiac surgical studies since it is a standard component 
of the treatment. It provides indication of the patient’s 
recovery profile and is in effect a composite measure of 
the entire perioperative process.30 Prolonged ICU stay is 
rare, being required in <10% of operated patients but it 
Table 2 Number of patients, expected number of outcomes within 90 days after cardiac surgery and included predictive 
variables and covariates for datasets 1, 2, 3 and 4
Development Validation
Dataset 1 Dataset 2 Dataset 3 Dataset 4
N 1143* 3347 982 333*
Period October 
2016 to February 2018
April 2013 to April 
2014
April 2013 to April 
2014
January 2019
Setting Rigshospitalet, 
Denmark
All Danish 
hospitals
Participants of 
DenHeart study from 
all Danish hospitals
Rigshospitalet, Denmark
Expected number of outcomes
  Death 40 117 35 12
  Length of admission 114 335 101 33
  Readmissions 229 669 202 67
Predictive variables Preoperative symptoms 
of anxiety, depression 
and frailty (when 
aged ≥65 years)
Socioeconomic 
position, 
cohabitation and 
comorbidity
Self-reported health 
and quality of life
Preoperative symptoms of anxiety, 
depression and frailty (when 
aged ≥65 years)
Socioeconomic position, cohabitation and 
comorbidity
Self-reported health and quality of life
Covariates 
  Model 1 Age and sex Age and sex Age and sex Age and sex 
  Model 2 EuroSCORE EuroSCORE EuroSCORE EuroSCORE
*Estimated number of patients to be included based on expected incidence of death following cardiac surgery of 3.5%.
Figure 2 Flowchart, dataset 1. HADS, Hospital Anxiety and 
Depression Scale. Figure 3 Flowchart, dataset 2.
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utilises >30% of all the ICU resources needed for cardiac 
surgery.45 In previous studies, prolonged length of stay 
in the ICU has been defined as >24 to >96 hours.3 46–51 
For the present study, based on existing literature and 
clinical framework, prolonged length of stay in the ICU 
is defined as >72 hours. To further quantify the degree 
of complications leading to prolonged admission to 
the ICU, supplementary analyses will be performed for 
selected ICU-related outcomes such as mechanical venti-
lation and use of inotropes or vasopressors.52
Predictors, rationale and measures
With this study, variables reflecting emotional, 
behavioural, social and functional factors will be evalu-
ated. All suggested predictors including categorisation 
are presented in table 1.
Potential predictors were chosen based on their clin-
ical relevance, prior findings of an association with the 
outcomes6 8 and the expected number of outcomes 
(tables 1 and2). The expected number of outcomes is 
listed in table 2.
Emotional factors
In patients undergoing cardiac surgery knowledge of 
prevalence and influence of emotional factors is lagging 
behind the evidence documented in other heart condi-
tions. In cardiac surgery, the emphasis has been on 
preserving cognitive function rather than mental health 
per se.53 Included emotional factors are anxiety, depres-
sion and health-related quality of life (HRQoL). Patients 
undergoing cardiac surgery will be assessed for symptoms 
of anxiety and depression 1 day prior to surgery (dataset 
1) with the Hospital Anxiety and Depression Scale 
(HADS), a validated questionnaire assessing depression 
and anxiety in hospitalised patients.54 A score of 7 or less 
indicates non-cases, scores of 8–10 for doubtful cases and 
scores of 11 or more for definite cases.54
HRQoL will be measured by HeartQoL and 12-Item 
Short-Form Health Survey (SF-12).
HeartQoL is a disease-specific tool comprising 14 items, 
with 10-item physical and 4-item emotional subscales, 
which are scored from 0 (poor HRQoL) to 3 (best).55 
With Cronbach's α between 0.80 and 0.91 for the global 
score and each subscale, the tool has been found reli-
able in patients with a wide range of cardiac diagnoses.55 
HeartQoL quantities are converted to binary quantities 
based on the median score.
The SF-12 constitutes the measure of mental and 
physical health.56 SF-12 is a generic measure shown 
useful in measuring physical and mental health even 
in smaller populations.57 58 Individual mental compo-
nent summary scores and physical component summary 
scores (PCS) ranging from 0 to 100 will be calculated 
based on the user’s manual.58 Higher scores indicate 
better health states. As recommended the cut-off will 
be set as the mean minus one SD, using the Danish 
normed score.57
Social factors
Several social factors have been found to be associated 
with outcomes following cardiac surgery. Measures of 
socioeconomic status (SES) have been found to influ-
ence disease incidence, treatment and health outcomes. 
Those with lower income, lower education or working in 
lower status occupations experience increased mortality 
and morbidity.22 25 27 59 SES will be measured by highest 
attained educational level and household equivalised 
disposable income, which is the household dispos-
able income divided by the number of members of the 
household converted into equalised adults. For this 
study, the equivalised disposable income will be stratified 
by ≤50% median, 51%–149% median and ≥150% median. 
Highest attained educational level will be defined as a 
maximum of 10 years of school, high school, vocational, 
higher education, undergraduate or postgraduate. 
Information on socioeconomic factors will be obtained 
from registers at Statistics Denmark. Furthermore, living 
alone has been linked with poor health outcomes in 
earlier studies, which may reflect that patients who are 
socially isolated are more likely to smoke and drink 
alcohol heavily,60 61 delay seeking treatment,62 demon-
strate non-compliance with medical regimens63 and may 
be due to lack of emotional or practical support gained 
through living with another person.64 The complexity of 
the influence of social connections on disease morbidity 
and mortality is simplified in a model by Holt-Lunstad 
and Smith shown in figure 5.65 Both married and cohab-
iting couples are included, as >20% of all couples living 
together in Denmark are in non-marital cohabiting rela-
tionships. To further investigate the influence of social 
connections, patients were asked two further questions in 
the DenHeart study—whether they experienced having 
someone to talk to if they needed support or were having 
problems and if they sometimes were alone, even though 
they would prefer to be with others.
Figure 4 Flowchart, dataset 3.
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Functional factors
Improved functional status is a major goal for most patients 
undergoing cardiac surgery. Indeed, disability, functional 
decline and frailty have been found to be predictive of 
mortality, major morbidity and complications following 
cardiac surgery.66–69 For this study, frailty will be measured 
preoperatively in patients aged 70+ years by the 5-metre 
Gait speed test.
Emotional and cognitive functioning will be measured 
by the Brief Illness Perception Questionnaire (B-IPQ), 
which has eight items comprising cognitive and emotional 
illness perceptions. Each dimension is assessed on a 
scale from 0 to 10 with higher scores indicating stronger 
perceptions. Five of the items assess cognitive illness 
representations, two assess emotional representations 
and one item assesses illness comprehensibility.70 71 The 
eight items (consequences, timeline, personal control, 
treatment control, identity, illness concern, coherence 
and emotional representation) may be combined as one 
total score, or each item may be assessed separately.72 No 
clear cut-offs for screening have been determined for 
B-IPQ. To reduce the df only the summary score will be 
included for the main analyses in three categories based 
on the 25th and 75th quartile in the studied sample.
Behavioural factors
Behavioural factors have previously been linked with 
outcomes following cardiac surgery. Several studies 
demonstrate that health-risk behaviours such as smoking, 
alcohol consumption, sedentary lifestyle and obesity 
are associated with a variety of diseases and mortality.73 
Smoking status will be included as current, ex-smoker 
and never smoking. Heavy alcohol consumption will be 
defined as >14/21 U/week for women and men, respec-
tively. BMI was considered for EuroSCORE II, but BMI 
was only weakly related to mortality risk (p=0.08) and was 
therefore not included in the final model. However, in 
the current study BMI will be included since outcomes 
other than mortality are included.
Complications related to anaesthesia and surgery are 
important to patients and expensive for the healthcare 
system. Postoperative complications result in increased 
morbidity and mortality, and extended hospital stay and 
convalescence.
statistical analysis
Data management will proceed without examining 
predictor–outcome associations. Continuous predictors 
are categorised (table 2). In case of patients undergoing 
surgery more than once in the inclusion periods, only the 
first entry will be included.
All analyses will consist of separate models for each 
of the datasets 1, 2 and 3 since they represent different 
populations.
The questionnaires described above, HeartQoL (phys-
ical) and SF-12 (PCS) both measure a physical compo-
nent of HRQoL. In order to be able to reduce the df, 
a correlation analysis on the two scales in dataset 3 will 
be conducted. In case of high correlations, the scale with 
the strongest association with outcomes will be chosen for 
inclusion.
To evaluate selection bias in the included data, a 
non-responder analysis will be conducted to compare 
responders and non-responders in the survey data by 
register-based information (datasets 1 and 3).
In case of missingness of predictors, single mean impu-
tation for each item will be performed for continuous 
variables while for categorical variables missing values will 
be assigned to the category most frequently occurring. If 
>10% are missing, best–worst case analyses will be done 
Figure 5 A simplified model of possible direct and indirect pathways by which social connections influence disease morbidity 
and mortality.66
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as sensitivity analyses where best case means that patients 
with primary outcome will have low predictor level and 
worst case means that patients with primary outcome will 
have highest predictor level. This will be done to evaluate 
the most extreme possible datasets.
Variable selection
Logistic regression analyses will be used to investigate the 
relationship between the prognostic variables and the 
outcomes.
Since the interest of this study is to examine whether 
emotional, behavioural, social and functional factors add 
to the existing EuroSCORE, the incremental value of 
each added variable will be determined by comparison 
of the predictive value of the model with and without 
the added variables in addition to the EuroSCORE. As 
the first descriptive reporting, each candidate predictor 
variable will be included separately in a model with the 
EuroSCORE. In the model development, each potential 
predictive variable will be removed stepwise from the 
model by using an automated backwards selection proce-
dure. We will use the Akaike’s Information Criterium to 
determine which predictors to include and set a liberal 
significance level of 0.10.
Scoring
The risk score will be calculated by a sum of the prod-
ucts of individual values of each predictor variable and 
its regression coefficient.74 To examine the performance 
of the prognostic model, patients will be classified as low 
(<3%), moderate (3%–5%) and high (>5%) risk.
Model performance
To examine the apparent performance (internal validity) 
of the prognostic screening tools, we will assess the 
risk score on discrimination, calibration and overall 
performance.
Discrimination refers to the ability of the model to 
separate patients who develop events from those who do 
not.75 To identify the discrimination of the model only 
including EuroSCORE and the final model, c-statistics for 
discriminative ability will be estimated and the receiver 
operating characteristic curve (ROC) by area under the 
ROC curve (AUC) will be presented.
Calibration measures how accurately the model’s 
predictions match overall observed event rates.75 We will 
evaluate the calibration of the model only including the 
EuroSCORE and the final model by a calibration plot, 
where we plot the observed outcome by decile of the 
predictions.76 To quantify the performance of the model 
in terms of calibration the calibration plot will be charac-
terised by an intercept a, which indicates the extent that 
predictions are systematically too low or too high, and a 
calibration slope b, which should be 1.76
To measure the overall performance of the model, 
the scaled Brier score will be applied by calculating the 
distance between the predicted outcome and actual 
outcome taking account of the maximum Brier value. 
The scaled Brier score will range from 0% with a perfect 
fitting model to 100% for a non-informative model.76
Adjustment for competing risks due to mortality will 
be included in the statistical analyses repeating the eval-
uation of discrimination, calibration and model perfor-
mance among patients that survive at least 90 days after 
surgery.
Measures of discrimination, calibration and model 
performance may not be sensitive when including new 
predictors to an existing model.76 Therefore, when 
comparing the model only with the EuroSCORE with 
the final model, we will also calculate measures of 
reclassification. This is done by supplementary anal-
yses evaluating how many patients change categories 
(low, medium and high risks as defined above) in the 
final model compared with the model only including 
EuroSCORE.77
Validation stage
In this stage, we will complete a prospective study to 
determine the predictive validity of the derived risk assess-
ment tool. For the external model validation predictor 
and outcome values will be measured among other 
patients from a validation cohort providing independent 
data. The derived model, with its predictors and assigned 
weights, as estimated from the development stage will be 
applied to these data, and the model’s predictive perfor-
mance will be quantified.78
Validation sample (dataset 4)
The validation sample will consist of a dataset including 
every adult patient undergoing primary, redo or emer-
gency cardiac surgery at one large urban hospital. 
Included patients will be scored and classified according 
to the derived prediction model from the development 
stage as having low (<3%), moderate (3%–5%) or high 
(>5%) risk of outcomes occurring. Patients will then be 
followed for mortality, prolonged length of admission 
and readmission up to 3 months after cardiac surgery in 
nationwide registers and clinical databases. For patients 
from the validation sample which have missing informa-
tion on some of the predictors in the risk model mean 
imputation will be performed. The model will be eval-
uated by calculating the measures of discrimination, 
calibration and model performance as described above. 
Information on expected sample size and number of 
outcomes is available in table 2.
In case of poor performance of the final model in 
the validation sample, updating of the model will be 
performed by re-estimation of predictor weights or 
adding or removing existing predictors from the original 
model.79
Presentation of the model
Based on the performance of the model in the valida-
tion sample, a nomogram or online calculator will be 
developed.
Protected by copyright.
 o
n
 Septem
ber 26, 2019 at Kobenhavns Universitets Bibliotek.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-026745 on 3 July 2019. Downloaded from 
8 Cromhout PF, et al. BMJ Open 2019;9:e026745. doi:10.1136/bmjopen-2018-026745
Open access 
Patient and public involvement
The described study does not include patient or public 
involvement since part of the data collection had been 
performed when the idea for the study was formulated. 
This is the first time patient reported outcomes are 
included in a risk assessment model for cardiac surgery, 
based on knowledge that several patient reported 
outcomes have been found to be associated with hard 
endpoints. Thus, it was not relevant for the current 
study to include patient preferences; however, findings 
from this study will be disseminated among patients and 
patient organisations.
dIsCussIon
This paper describes the material and statistical anal-
ysis plan to develop and validate a prognostic screening 
tool for patients undergoing cardiac surgery, following 
the PROGRESS framework and TRIPOD reporting 
guidelines. The prognostic screening tool consists of 
the existing EuroSCORE with added variables reflecting 
emotional, behavioural, social and functional factors. 
Several of the included predictors are based on existing 
data measured in previously collected datasets; however, 
some predictors were based on data primary collected for 
this study. The analysis of existing data is an expedient 
way to make full use of data that are already collected to 
address potentially important new research questions,80 
and furthermore an effort to avoid disturbing patients 
unnecessarily. The study described uses corresponding 
datasets from multiple studies. When doing this, there is 
a risk that the datasets differ in important aspects, such as 
baseline risk. However, in the described study a prediction 
model will be developed for each dataset avoiding bias 
due to this. In the external validation stage, the models 
will be combined and tested in one dataset.78
The risk score calculations available for datasets 2 and 
3 are calculated based on EuroSCORE I and not the 
updated EuroSCORE II. EuroSCORE I has been found 
to over-estimate12 and EuroSCORE II to under-estimate 
mortality.13 81 82 It is therefore reasonable to assume that 
the potential improvement of the model is not attribut-
able to the choice of EuroSCORE model.
Potential predictors chosen for this study have in earlier 
studies been found to be associated with poor outcomes 
following cardiac surgery, not only from Denmark, 
but internationally. Furthermore, potential predictors 
included in this study represent common traits and issues 
that should be easily collected in different settings. Thus, 
results from this study has the potential to be generalised 
to countries outside of Denmark. However, external vali-
dation on datasets from other institutions are required to 
confirm this.
According to the TRIPOD guidelines in prediction 
model studies, the outcome is ideally assessed while 
blinded to information about the predictors.33 The predic-
tors may otherwise influence the outcome assessment. 
However, this risk is limited for the objective outcomes 
included in the present study where the collection of 
outcome data is from administrative registers without the 
influence of the investigator. Furthermore, the quality of 
the follow-up data is exceptional for Denmark due to the 
comprehensive national registers.83
The relative importance of calibration and discrimina-
tion ultimately depends on the purpose of the screening 
tool. Thus, if the purpose of the tool is to aid clinical deci-
sion-making and provides accurate estimates of risk to 
patients, then calibration is most important. If clinicians 
were to inform patients of their risk of dying following 
cardiac surgery, this estimate would be misleading if 
the tool was not well calibrated and, for example, more 
patients with the same level of risk than estimated died 
following cardiac surgery. If, on the other hand, the 
purpose of the tool is to select appropriate patients to 
include in a randomised trial, for example, in a trial with 
the purpose to reduce poor outcome following cardiac 
surgery then adequate discrimination is important. In 
that case, a poorly discriminating tool would misclassify 
a large proportion of patients, including several inap-
propriate (low risk) patients and excluding appropriate 
(high risk) patients.
The suggested study of the development and validation 
of a prognostic screening tool for patients undergoing 
cardiac surgery may provide a foundation to determine 
the need for clinical interventions aimed at reducing 
the risk associated with cardiac surgery. Furthermore, 
the addition of non-medical parameters can potentially 
improve the risk evaluation process to make the predic-
tion by risk assessment models more accurate and with 
higher discrimination leading to greater public accep-
tance of the resulting decisions.
ConClusIon
This protocol outlines the design of the developing and 
validating studies for a prognostic screening tool for 
patients undergoing cardiac surgery. Results coming 
from this study will be interpreted for both clinical and 
research purposes.
EthICs And dIssEMInAtIon
The study will follow the requirements from the Ethical 
Committee System ensuring voluntary participation in 
accordance with the Helsinki declarations. According to 
Danish legislation, surveys do not have to be approved by 
an ethics committee system. A consent form was signed by 
all participating patients.
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